Abstract A82: Metronomic cyclophosphamide followed by a multi-peptide folate receptor vaccine for ovarian and breast cancer immunotherapy in the setting of minimal residual disease - a feasibility study

Kimberly R. Kalli, Keith L. Knutson, James Krempski et al.|Clinical Cancer Research|2013

Cited by 0